Worn-out knees regrew their cushioning in mice. The target was one ageing enzyme
What happened
On 6 October 2026, researchers led by Stanford Medicine published a study in the journal Science about regrowing cartilage in knees. Cartilage is the smooth, slippery layer that covers the ends of your bones inside a joint. It lets the joint glide. When it wears away, bone rubs on bone. That is osteoarthritis, and it is one of the main reasons people end up needing a knee or hip replacement. For a long time the medical view has been that adult cartilage barely repairs itself. Once it is gone, it is gone. The Stanford team went after an enzyme called 15-PGDH. An enzyme is a protein that speeds up a chemical reaction in the body. The amount of 15-PGDH in our tissues goes up as we get older, and the researchers describe it as a "gerozyme": an enzyme that rises with age and makes tissue work less well. When they gave older mice a drug that blocks 15-PGDH, the cartilage in their knees grew back. Not scar tissue, but hyaline cartilage, the proper smooth kind that joints actually need. They also injured the knees of mice in a way that is similar to an ACL tear in a person. Untreated mice went on to develop osteoarthritis within about four weeks. Mice given the blocker were far less likely to. Then they tried it on human tissue. They took cartilage samples from people who had had knee replacement surgery and exposed them to the 15-PGDH blocker in the laboratory. The share of cells producing 15-PGDH fell from about 8% to about 3%. After a week, the human tissue had started to regenerate articular cartilage, and genes linked to cartilage breaking down became less active. Senior author Professor Helen Blau said: "This is a new way of regenerating adult tissue, and it has significant clinical promise for treating arthritis due to aging or injury."
Why this matters
Osteoarthritis is extremely common and there is still no treatment that reverses it. What we have is pain relief, physiotherapy, weight management, walking aids and, eventually, joint replacement surgery. Joint replacement works well for many people, but it is major surgery, it needs recovery time, and artificial joints do not last forever. A medicine that rebuilt the cushioning instead would be a different kind of answer altogether. There is a second reason this result has caught attention. A tablet version of a 15-PGDH blocker is already being tested in human trials, aimed at age-related muscle weakness. That means some of the early safety work on this type of drug is already under way. It does not mean a knee treatment is close, but it is not starting from nothing either.
What the evidence actually says
This is the part that matters most, and it is worth reading slowly. The cartilage regrowth happened in mice. Mice are not people. A great many treatments that work beautifully in mice do not work in humans, or cause side effects that only show up later. The human part of the study was tissue in a dish, not patients. Cartilage taken out at surgery and treated in a laboratory is a useful signal that the biology may carry across to humans. It is not evidence that injecting or swallowing this drug helps a person's knee. No clinical trial of this treatment in people with osteoarthritis has been completed. Until that happens, nobody knows whether it works in a living human joint, what dose would be needed, how long any benefit would last, or what the risks are. There is also a general caution with ageing enzymes. 15-PGDH is not there by accident; it has jobs elsewhere in the body. Blocking something that rises with age across many tissues needs careful safety study. The honest summary: this is a genuinely interesting piece of laboratory science, published in a leading journal, that opens a new route. It is not a treatment you can ask for, and it will be years before anyone knows whether it becomes one.
Practical advice
If you have knee pain or osteoarthritis now, nothing in this study changes what you should do today. Keep moving. It feels wrong when a joint hurts, but gentle regular activity is one of the best-evidenced things for osteoarthritis. Walking, swimming and cycling are usually kinder to knees than running. Strengthen the muscles around the joint. Strong thigh muscles take load off the knee itself. A physiotherapist can show you a few exercises that take minutes a day. If you carry extra weight, losing some reduces the force going through the joint with every step. Even a modest loss helps. Use pain relief sensibly and ask your pharmacist about it. Some anti-inflammatory tablets and gels do not mix well with other medicines, with stomach problems or with kidney conditions. A pharmacist can check that in a couple of minutes. Be careful with supplements sold online as cartilage rebuilders. The evidence for most of them is weak, and a headline about a mouse study is often used within days to sell something. If a product claims to do what this research did, treat that claim with suspicion. If your knee has locked, given way, swollen suddenly or you cannot put weight on it, get it looked at rather than waiting.
What to know
Stanford-led researchers blocked an ageing enzyme called 15-PGDH and regrew proper knee cartilage in old mice. The same treatment protected mice from arthritis after an ACL-style injury, and human cartilage taken at surgery began to regenerate in the laboratory. The study was published in Science on 6 October 2026. It is early-stage work: mice and tissue samples, not patients. There is no approved treatment, and clinical trials in people with osteoarthritis have not been done. For now, the things that genuinely help osteoarthritis are the unglamorous ones: keep moving, build up the muscles around the joint, manage weight, and get pain relief checked so it is safe alongside your other medicines. Sources: ScienceDaily (reporting Stanford Medicine research published in Science, 2026, vol 391), 'Goodbye joint replacements? Stanford scientists found a way to regrow cartilage and stop arthritis', 6 October 2026, https://www.sciencedaily.com/releases/2026/10/261005011249.htm ; US Pharmacist, 'Researchers Regrow Cartilage and Halt Arthritis', October 2026, https://www.uspharmacist.com/article/researchers-regrow-cartilage-and-halt-arthritis- ; NHS, 'Osteoarthritis', https://www.nhs.uk/conditions/osteoarthritis/ This article is for general information and does not replace advice from a doctor, pharmacist, physiotherapist or other qualified healthcare professional. Do not start or stop any treatment for joint pain on the strength of a news story.
Related articles
Six hours, not never: the ICU filter notice the MHRA issued today
The UK's medicines and devices regulator has issued a new safety notice to hospitals, and it is about timing. On 13 October 2026 the Medicines and Healthcare p…
Eight pages to a minister: what the data guardian says trust is worth
On 12 October 2026, the government published a letter about who should be trusted with NHS patient data. It was written by Dr Nicola Byrne, the National Data G…
Update: the tests came back, and it was not plague
This is a follow-up to a story we covered on 5 October, when nearly 200 people were being monitored after the death of a laboratory worker in Siberia. There has…